A detailed history of Icon Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Icon Wealth Advisors, LLC holds 2,320 shares of VRTX stock, worth $1.17 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,320
Previous 2,635 11.95%
Holding current value
$1.17 Million
Previous $1.1 Million 1.27%
% of portfolio
0.09%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $123,735 - $152,941
-315 Reduced 11.95%
2,320 $1.09 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $20,384 - $22,304
-50 Reduced 1.86%
2,635 $1.1 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $97,755 - $117,043
-285 Reduced 9.6%
2,685 $1.09 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $36,863 - $41,470
-129 Reduced 4.16%
2,970 $857,000
Q3 2022

Jan 25, 2023

BUY
$273.83 - $305.53 $848,599 - $946,837
3,099 New
3,099 $897,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Icon Wealth Advisors, LLC Portfolio

Follow Icon Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Advisors, LLC with notifications on news.